Literature DB >> 25704806

Adenosine A2b receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus.

Francisco Q Gonçalves1, Johny Pires, Anna Pliassova, Rui Beleza, Cristina Lemos, Joana M Marques, Ricardo J Rodrigues, Paula M Canas, Attila Köfalvi, Rodrigo A Cunha, Daniel Rial.   

Abstract

Adenosine is a neuromodulator mostly acting through A1 (inhibitory) and A2A (excitatory) receptors in the brain. A2B receptors (A(2B)R) are G(s/q)--protein-coupled receptors with low expression in the brain. As A(2B)R function is largely unknown, we have now explored their role in the mouse hippocampus. We performed electrophysiological extracellular recordings in mouse hippocampal slices, and immunological analysis of nerve terminals and glutamate release in hippocampal slices and synaptosomes. Additionally, A(2B)R-knockout (A(2B)R-KO) and C57/BL6 mice were submitted to a behavioural test battery (open field, elevated plus-maze, Y-maze). The A(2B)R agonist BAY60-6583 (300 nM) decreased the paired-pulse stimulation ratio, an effect prevented by the A(2B)R antagonist MRS 1754 (200 nM) and abrogated in A(2B)R-KO mice. Accordingly, A(2B)R immunoreactivity was present in 73 ± 5% of glutamatergic nerve terminals, i.e. those immunopositive for vesicular glutamate transporters. Furthermore, BAY 60-6583 attenuated the A(1)R control of synaptic transmission, both the A(1)R inhibition caused by 2-chloroadenosine (0.1-1 μM) and the disinhibition caused by the A(1)R antagonist DPCPX (100 nM), both effects prevented by MRS 1754 and abrogated in A(2B)R-KO mice. BAY 60-6583 decreased glutamate release in slices and also attenuated the A(1)R inhibition (CPA 100 nM). A(2B)R-KO mice displayed a modified exploratory behaviour with an increased time in the central areas of the open field, elevated plus-maze and the Y-maze and no alteration of locomotion, anxiety or working memory. We conclude that A(2B)R are present in hippocampal glutamatergic terminals where they counteract the predominant A(1)R-mediated inhibition of synaptic transmission, impacting on exploratory behaviour.
© 2015 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  A1 receptors; A2B receptor; Adenosine; hippocampus; nerve terminal; receptor interaction

Mesh:

Substances:

Year:  2015        PMID: 25704806     DOI: 10.1111/ejn.12851

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  17 in total

1.  Adenosine receptor distribution in Rhesus monkey ocular tissue.

Authors:  Krista M Beach; Li-Fang Hung; Baskar Arumugam; Earl L Smith; Lisa A Ostrin
Journal:  Exp Eye Res       Date:  2018-05-21       Impact factor: 3.467

2.  Tremorolytic effect of 5'-chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A1 receptor agonist, evaluated in the harmaline-induced model in rats.

Authors:  Barbara Kosmowska; Krystyna Ossowska; Urszula Głowacka; Jadwiga Wardas
Journal:  CNS Neurosci Ther       Date:  2017-03-29       Impact factor: 5.243

3.  Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3am-/p+ Mice Modelling Angelman Syndrome Are Attenuated by Adenosine A2A Receptor Blockade.

Authors:  Ana Moreira-de-Sá; Francisco Q Gonçalves; João P Lopes; Henrique B Silva; Ângelo R Tomé; Rodrigo A Cunha; Paula M Canas
Journal:  Mol Neurobiol       Date:  2021-01-19       Impact factor: 5.590

4.  The impact of inosine on hippocampal synaptic transmission and plasticity involves the release of adenosine through equilibrative nucleoside transporters rather than the direct activation of adenosine receptors.

Authors:  Pedro Valada; Sonja Hinz; Christin Vielmuth; Cátia R Lopes; Rodrigo A Cunha; Christa E Müller; João Pedro Lopes
Journal:  Purinergic Signal       Date:  2022-09-26       Impact factor: 3.950

5.  Adenosine A1 receptor antagonist-induced facilitation of postsynaptic AMPA currents in pyramidal neurons of the rat hippocampal CA2 area.

Authors:  Masahito Kawamura; Yuko Sekino
Journal:  Purinergic Signal       Date:  2022-09-08       Impact factor: 3.950

6.  A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction.

Authors:  Jennifer Gile; Yoshimasa Oyama; Sydney Shuff; Tobias Eckle
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

7.  Activation of adenosine A2A or A2B receptors causes hypothermia in mice.

Authors:  Jesse Lea Carlin; Shalini Jain; Romain Duroux; R Rama Suresh; Cuiying Xiao; John A Auchampach; Kenneth A Jacobson; Oksana Gavrilova; Marc L Reitman
Journal:  Neuropharmacology       Date:  2018-03-13       Impact factor: 5.250

8.  Adenosine A2B receptor activation stimulates glucose uptake in the mouse forebrain.

Authors:  Cristina Lemos; Bárbara S Pinheiro; Rui O Beleza; Joana M Marques; Ricardo J Rodrigues; Rodrigo A Cunha; Daniel Rial; Attila Köfalvi
Journal:  Purinergic Signal       Date:  2015-10-07       Impact factor: 3.765

9.  Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation.

Authors:  Dasiel O Borroto-Escuela; Sonja Hinz; Gemma Navarro; Rafael Franco; Christa E Müller; Kjell Fuxe
Journal:  Front Neurosci       Date:  2018-02-06       Impact factor: 4.677

10.  Effects of the adenosinergic system on the expression and acquisition of sensitization to conditioned place preference in morphine-conditioned rats.

Authors:  Joanna Listos; Sylwia Talarek; Piotr Listos; Jolanta Orzelska; Małgorzata Łupina; Sylwia Fidecka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.